Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia	Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Diabetes Complications, Diabetic Foot, Disease Attributes, Foot Ulcer, Leg Ulcer, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Ulcer, Skin and Connective Tissue Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, diabetes mellitus, diabetic neuropathy, diabetic peripheral angiopathy, endocrine system disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, skin disorder, vascular disorder	Not yet recruiting	Phase 4	2026-09-18		NCT07827521

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing Northland Biotech. Co., Ltd.	3
First Affiliated Hospital of Wenzhou Medical University	117

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Hangzhou First People's Hospital	Hangzhou	China	1
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine	Hangzhou	China	1
Taizhou Hospital of Zhejiang Province	Taizhou	China	1
The First Affiliated Hospital of Wenzhou Medical University	Wenzhou	China	1
The First Affiliated Hospital, Zhejiang University School of Medicine	Hangzhou	China	1
Zhejiang Provincial People's Hospital	Hangzhou	China	1